Table 3 Number of patients treated in the public sector versus the private sector
Formulation | Anti-malarial | Patients treatedb (n, %) | |
|---|---|---|---|
Public sector 1820 (46.7) | Private sector 2080 (53.3) | ||
Tablets | Amodiaquine | 0 | 0 |
Artemether | 0 | 5 (0.2) | |
Artemether/lumefantrine | 1715 (94.2) | 1029 (49.5) | |
Chloroquine | 0 | 3 (0.1) | |
Dihydroartemisinin/piperaquine | 0 | 19 (0.9) | |
Quinine | 2 (0.1) | 169 (8.1) | |
Sulfadoxine/pyrimethamine | 96 (5.3) | 341 (16.4) | |
Parenteral | Artemether | 0 | 31 (1.5) |
Artesunate | 47 (2.6) | 73 (3.5) | |
Quinine | 12 (0.7) | 285 (13.7) | |
Syrup | Quinine | 0 | 164 (7.9) |
Rectal | Artesunate | 7 (0.4)a | 0 |